Moving Forward in Smoking Cessation: Issues for Psychiatric Nurses

Abstract

Get full access to this article

View all access options for this article.

References

American Association of Medical Colleges. ( 2007). Physician behavior and practice patterns related to smoking cessation. Retrieved November 2, 2008, from http://www.aamc.org/workforce/smoking-cessation-full.pdf

American Psychiatric Nurses Association. ( 2008). Smoking cessation position statement: Psychiatric nurses as champions for smoking cessation. Retrieved November 12, 2008, from http://www.apna.org/i4a/pages/index.cfm?pageid=3751

Benowitz, N.L. (2008). Clinical pharmacology of nicotine: Implications for understanding, preventing, and treating tobacco addiction. Clinical Pharmacology and Therapeutics, 83, 531-541.

Bjornson, W. (2008, January). Bringing everyone along resource guide: For health professional providing tobacco cessation services for people with mental illness and substance use disorder. Portland, OR : Tobacco Cessation Leadership Network.

Brown, R.A. , Kahler, C.W. , Niaura, R. , Abrams, D.B. , Sales, S.D. , Ramsey, S.E. , et al. (2001). Cognitive-behavioral treatment for depression in smoking cessation. Journal of Consulting and Clinical Psychology , 69, 471-480.

Brown, R.A. , Niaura, R. , Lloyd-Richardson, E.E. , Strong, D.R. , Kahler, C.W. , Abrantes, A.M. , et al. (2007). Bupropion and cognitive-behavioral treatment for depression in smoking cessation. Nicotine & Tobacco Research, 9, 721-730.

Burke, M. (2006). Technical report on smoking policy and treatment in state operated psychiatric facilities. In J. Parks & P. Jewell (Eds.), Technical report 12. Alexandria, VA: National Association of State Mental Health Program Directors Medical Directors Council.

Centers for Disease Control and Prevention. ( 2002). Cigarette smoking among adults-United States, 2000. Morbidity and Mortality Weekly Report, 51, 642-645.

Centers for Disease Control and Prevention. ( 2008, November 14). Cigarette smoking among adults-United States, 2007. Morbidity and Mortality Weekly Report, 57, 1221-1226.

10.

Christakis, N.A. , & Fowler, J.H. (2008). The collective dynamics of smoking in a large social network. New England Journal of Medicine, 358, 2249-2258.

11.

Colton, C.W. , & Manderscheid, R.W. (2006, April). Congruencies in increased mortality rates, years of potential lives lost, and causes of death among public health mental clients in eight states [Electronic version] . Preventing Chronic Disease, 3(2). Retrieved November 1, 2008, from http://cdc.gov/pcd/issues/2006/Apr/05_0180.htm

12.

Dierker, L.C. , Avenevoli, S. , Merikangas, K.R. , Flaherty, B.P. , & Stolar, M. (2001). Association between psychiatric disorders and the progression of tobacco use behaviors. Journal of the American Academy of Child & Adolescent Psychiatry, 40, 1159-1167.

13.

Fiore, M.C. , Jaen, C.R. , Baker, T.B. , Bailey, W.C. , Benowitz, N.L. , Curry, S.J. , et al. (2008). Treating tobacco use and dependence: 2008 Update. Practice guideline. Rockville, MD: Public Health Service.

14.

Fowler, J.S. , Volkow, N.D. , Wang, G.J. , Pappas, N. , Logan, J. , MacGregor, R. , et al. (1996). Inhibition of monoamine oxidase B in the brains of smokers. Nature, 379, 733-736.

15.

Gonzales, D. , Rennard, S.I. , Nides, M. , Oncken, C. , Azoulay, S. , Billing, C.B. , et al. (2006). Varenicline, an α4β2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 47-55.

16.

Grant, B.F. , Hasin, D.S. , Chou, P. , Stinson, F.S. , & Dawson, D.A. (2004). Nicotine dependence and psychiatric disorders in the United States: Results from the national epidemiologic survey on alcohol and related conditions. Archives of General Psychiatry, 61, 1107-1115.

17.

Hays, J.T. , & Ebbert, J.O. (2008). Varenicline for tobacco dependence. New England Journal of Medicine, 359, 2018-2024.

18.

Jorenby, D.E. , Hays, J.T. , Rigotti, N.A. , Azoulay, S. , Watsky, E.J. , Williams, K.E. , et al. (2006). Efficacy of varenicline, an α4β2 nicotinic acetaldehyde receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: A randomized controlled trial. Journal of the American Medical Association, 296, 56-63.

19.

Kalman, D. , Morissette, S.B. , & George, T.P. (2005). Co-morbidity of smoking in patients with psychiatric and substance abuse disorders. American Journal on Addictions , 14, 106-123.

20.

Lasser, K. , Boyd, J.W. , Woolhandler, S. , Himmelstein, D.U. , McCormick, D. , & Bor, D.H. (2000). Smoking and mental illness: A population-based prevalence study. Journal of the American Medical Association , 284, 2606-2610.

21.

Lerman, C. , Caporaso, N. , Main, D. , Audrain, J. , Boyd, N.R. , Bowman, E.D. , et al. (1998). Depression and self-medication with nicotine: The modifying influence of the dopamine D4 receptor gene. Health Psychology, 17, 56-62.

22.

Levin, A. (2007). State hospitals struggle to give up smoking. Psychiatric News, 42(22), 4.

23.

Lucksted, A. , McGuire, C. , Postrado, L. , Kreyenbuhl, J. , & Dixon, L.B. (2004). Specifying cigarette smoking and quitting among people with serious mental illness. American Journal on Addictions , 13, 128-138.

24.

Mauer, B. (2006). Morbidity and mortality in people with serious mental illness. In J. Parks , D. Svendsen , P. Singer , & M. E. Foti (Eds.), Technical report 13. Alexandria, VA: National Association of State Mental Health Program Directors Council.

25.

McCaffery, J.M. , Niaura, R. , Swan, G.E. , & Carmelli, D. (2003). A study of depressive symptoms and smoking behavior in adult male white twins from the NHLBI twin study. Nicotine & Tobacco Research, 5, 77-83.

26.

Mechanic, D. , Blider, S. , & McAlpine, D.D. (2002). Employing persons with serious mental illness. Health Affairs (Project Hope) , 21, 242-253.

27.

Paperwalla, K.N. , Levin, T.T. , Weiner, J. , & Saravay, S.M. (2004). Smoking and depression. Medical Clinics of North America, 88, 1483-1494.

28.

Prochaska, J.J. , Rossi, J.S. , Redding, C.A. , Rosen, A.B. , Tsoh, J.Y. , Humfleet, G.L. , et al. (2004). Depressed smokers and stage of change: Implications for treatment interventions. Drug and Alcohol Dependence, 76, 143-151.

29.

Prochaska, J.O. , DiClemente, C.C. , & Norcross, J.C. (1992). In search of how people change. Applications to addictive behaviors. American Psychologist , 47, 1102-1114.

30.

The Regents of the University of California, University of Southern California, and Western University of Health Sciences. ( 2007). Rx for change: Clinician-assisted tobacco cessation. San Francisco: Author. Retrieved November 2, 2008, from http://rxforchange.ucsf.edu

31.

Reilly, P. , Murphy, L. , & Alderton, D. (2006). Challenging the smoking culture within a mental health service supportively. International Journal of Mental Health Nursing, 15, 272-278.

32.

Sánchez-Villegas, A. , Serrano-Martínez, M. , Alonso, A. , de Irala, J. , Tortosa, A. , & Martínez-González, M.A. (2008). Role of tobacco use on the incidence of depression in the SUN cohort study. Medicina Clínica, 130, 405-409.

33.

Schroeder, S.A. (2007a). Shattuck Lecture. We can do better- Improving the health of the American people. New England Journal of Medicine, 357, 1221-1228.

34.

Schroeder, S.A. (2007b, November 18). A hidden epidemic. Washington Post, p. B07.

35.

Schroeder, S.A. (2008). Stranded in the periphery-The increasing marginalization of smokers. New England Journal of Medicine, 358, 2284-2296.

36.

Schroeder, S.A. (in press). Clinical crossroads: A 51-year-old woman with bipolar disorder who wants to quit smoking. Journal of the American Medical Association.

37.

Schroeder, S.A. , & Sox, H.C. (2006). Trials that matter: Varenicline: A designer drug to help smokers quit. Annals of Internal Medicine, 145, 784-785.

38.

Steinberg, M.L. , Williams, J.M. , & Ziedonis, D.M. (2004). Financial implications of cigarette smoking among individuals with schizophrenia. Tobacco Control, 13, 206.

39.

Tsoh, J.Y. , & Hall, S.M. (2004). Depression and smoking: From the transtheoretical model of change perspective. Addictive Behaviors, 29, 801-805.

40.

Williams, J.M. (2008). Eliminating tobacco use in mental health facilities: Patients' rights, public health, and policy issues. Journal of the American Medical Association, 299, 571-573.

41.

Williams, J.M. , & Ziedonis, D. (2004). Addressing tobacco among individuals with a mental illness or an addiction. Addictive Behaviors, 29, 1067-1083.

42.

Ziedonis, D.M. , Kosten, T.R. , Glazer, W.M. , & Frances, R.J. (1994). Nicotine dependence and schizophrenia. Hospital & Community Psychiatry, 45, 204-206.